Machida Masaki, Inoue Shigeru, Furuse Yuki, Oka Emiko, Ueda Yutaka, Fukushima Shinji, Tabuchi Takahiro
Department of Preventive Medicine and Public Health, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan; Department of Infection Prevention and Control, Tokyo Medical University Hospital, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan.
Department of Preventive Medicine and Public Health, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan.
Vaccine. 2025 Aug 13;61:127434. doi: 10.1016/j.vaccine.2025.127434. Epub 2025 Jun 28.
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections and bronchiolitis in infants. A recently introduced maternal RSV vaccine is highly effective in reducing severe illnesses and could play a key role in preventing RSV infections in infants. However, vaccine hesitancy remains a global issue, and the knowledge and attitude toward RSV vaccines among pregnant women during the post-marketing phase are unclear. Therefore, this study aimed to identify the knowledge and attitude toward RSV vaccine and associated factors among pregnant women in Japan during the early post-marketing phase.
This exploratory cross-sectional study utilized data from a large-scale nationwide Internet survey conducted in Japan. Pregnant women were provided with five statements related to knowledge of RSV and vaccine against it, including clinical picture and vaccine eligibility, and questions to assess their willingness to be vaccinated. Modified Poisson regression analysis was performed to identify factors associated with willingness to be vaccinated. Independent variables included sociodemographic factors, general vaccination readiness, and knowledge level.
Among 300 pregnant women, 13.3 % expressed willingness to be vaccinated. Participants with knowledge of all five statements accounted for 8.3 %, whereas 40.0 % had no knowledge of RSV or the vaccine. High general vaccination readiness (prevalence ratio [PR] [95 % confidence interval (CI)]:2.02 [1.14-3.58]) and high knowledge levels (PR [95 % CI]: 1.20 [1.03-1.39]) were significantly associated with willingness to be vaccinated.
Willingness to be vaccinated during the early post-marketing phase appeared to be very low, and general vaccination readiness and their level of knowledge were positively associated with this intention. Participants with comprehensive knowledge were approximately 2.49 (= 1.20) times more likely to express willingness to be vaccinated than those with no knowledge. Increasing the awareness of RSV and improving vaccination readiness may be crucial for promoting RSV vaccine acceptance.
呼吸道合胞病毒(RSV)是婴儿下呼吸道感染和细支气管炎的主要病因。最近推出的母体RSV疫苗在降低重症疾病方面非常有效,并且可能在预防婴儿RSV感染中发挥关键作用。然而,疫苗犹豫仍然是一个全球性问题,在上市后阶段孕妇对RSV疫苗的知识和态度尚不清楚。因此,本研究旨在确定日本上市后早期孕妇对RSV疫苗的知识和态度以及相关因素。
这项探索性横断面研究利用了在日本进行的一项大规模全国性互联网调查的数据。向孕妇提供了五条与RSV及其疫苗知识相关的陈述,包括临床表现和疫苗适用性,以及评估她们接种意愿的问题。进行了修正泊松回归分析以确定与接种意愿相关的因素。自变量包括社会人口统计学因素、一般疫苗接种准备情况和知识水平。
在300名孕妇中,13.3%表示愿意接种疫苗。了解所有五条陈述的参与者占8.3%,而40.0%的人对RSV或疫苗一无所知。较高的一般疫苗接种准备情况(患病率比值[PR][95%置信区间(CI)]:2.02[1.14 - 3.58])和较高的知识水平(PR[95%CI]:1.20[1.03 - 1.39])与接种意愿显著相关。
上市后早期的接种意愿似乎非常低,一般疫苗接种准备情况和她们的知识水平与这种意愿呈正相关。具有全面知识的参与者表达接种意愿的可能性大约是一无所知者的2.49(= 1.20)倍。提高对RSV的认识和改善疫苗接种准备情况可能对促进RSV疫苗的接受至关重要。